- Report code
- MRIA001
- Published
- June 2026
- Pages
- 430
- Exhibits
- 92
- Major companies
- 40
- Directory listings
- 283
Abstract
This report on ADME/Tox Technologies gives a market insight into products and services used in the ADME/Tox industry. Predictive technologies analyzed include In vivo, In vitro, and In silico. Related technologies such as High Throughput Screening (HTS), Laboratory Information Management System (LIMS), and cell based assays are also analyzed. Market projections and estimates are illustrated by region and by technology. The report serves as a guide to ADME/Tox industry, covering more than 280 companies that are engaged in ADME/Tox studies/screening, products and services. Major Contract Research Organizations, Research Institutes and Universities serving the ADME/Tox industry are also covered in the corporate directory section of this report. Information related to recent product releases, product developments, partnerships, collaborations, and mergers and acquisitions is covered in the report. Compilation of Worldwide Patents related to ADME/Tox Technologies is also provided. A global perspective is presented along with regional analysis covering North America, Europe, Asia-Pacific, Latin America, the Middle East and Africa with 92 exclusive graphically represented exhibits.
Highlights
Global ADME/Tox Technologies market is projected to grow at a robust rate mainly driven by the efforts of pharmaceutical and biotech companies for reducing time and cost of drug discovery. ADME/Tox profiling of a drug candidate plays a key role in reducing clinical trials cost and time of drug launch to the market. ADME/Tox assays eliminate compounds with lack of bioavailability, lower efficacy and toxicity in early stages, in order to save time and costs in expensive later stages of drug discovery. Non-animal technologies, In vitro and In silico, are projected to expand their share of the market, with In silico projected to register the fastest growth rate across geographic markets.
Why buy this report
This report may help strategists, investors, laboratories, contract research organizations, biotechnology and healthcare companies, academic professionals, drug approval authorities and other organizations to
- Identify market opportunities
- Review and analyze global and regional markets
- Gauge market potential for your products
- Identify competition
- Acquire meaningful guidelines for strategic planning
- Gear up for market entry
- Get actionable information
Chapters
- Scope and MethodologyResearch methodology, limitations, market measuring units and exchange rates used.
- Report SynopsisGlobal ADME/Tox market by In vivo, In vitro and In silico technologies, with a list of major companies by technology.
- Market DynamicsGlobal and regional markets by technology and product segment across North America, Europe, Asia-Pacific and Rest of World, with market values for the countries covered and an industry outlook.
- Competitor DynamicsProfiles of major global companies and corporate activities including mergers and acquisitions, partnerships and new product developments.
- Product/Technology ResearchDefinitions, segmentation, applications, ADME/Tox methods, toxicity types, pharmaceutical and drug-discovery applications, industry challenges and research activity.
- Corporate DirectoryA global region-wise list of companies, CROs and academic institutions offering ADME/Tox products and services.
- Patents InformationWorldwide patents related to ADME/Tox products and services.
Table of contents
- Scope and Methodology
- Report Synopsis
- Market Dynamics
- Regional Analysis
- Product/Technology Research
- Competitor Dynamics
- Corporate Directory
- Patents Information
The full table of contents and list of exhibits come with the sample pages. Request sample pages.
Choose a licence
Reports are delivered as a PDF by email within one working day of payment. Payment by PayPal or by invoice. Read the licence terms and terms of sale.